Group One Trading, L.P. Adial Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.2 - $9.25 $11,284 - $521,903	-56,422 Reduced 99.65%	200 $0
Q3 2022 Nov 09, 2022	BUY	$0.03 - $46.0 $1,302 - $2 Million	43,433 Added 329.31%	56,622 $20,000
Q1 2022 May 12, 2022	BUY	$45.0 - $69.0 $314,505 - $482,241	6,989 Added 112.73%	13,189 $27,000
Q4 2021 Feb 11, 2022	BUY	$62.25 - $104.5 $385,950 - $647,900	6,200 New	6,200 $17,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.